• GMP-compliant cell culture medium optimises API manufacture
    Bottle of StemFit Basic04 CT.
  • Colony of iPSCs grown using StemFit Basic04 CT.

Reagents

GMP-compliant cell culture medium optimises API manufacture

Apr 30 2024

AMSBIO has unveiled an upgraded GMP-compliant version of its animal-origin-free, chemically defined StemFit™ iPSC expansion medium. StemFit™ Basic04 CT is engineered to enhance the growth and pluripotency of induced pluripotent stem cells (iPSC) while meeting the stringent Good Manufacturing Practice (GMP) standards for Active Pharmaceutical Ingredients (API).

With its superior iPSC performance, StemFit™ Basic04 CT facilitates expansion and sustains long-term genetic stability, optimising single-cell passaging for large-scale stem cell production. The manufacturing and quality control of this exciting new product are managed in strict accordance with GMP standards.

Each bottle of StemFit™ Basic04 CT is accompanied by a certificate of analysis and all necessary documentation, ensuring a seamless transition to clinical applications. Aisha Amari, Business Development specialist at AMSBIO, emphasised the significance of iPSCs in revolutionising cellular medicines and highlighted the pivotal role of GMP-compliant StemFit™ Basic04 CT in iPSC manufacturing for cell therapy.

Amari stated: "Using StemFit™, we hope researchers can further advance translational research, drug discovery and development and help bring high-quality iPSC based- therapies from bench to bedside."

More information online


Digital Edition

LMUK 49.7 Nov 2024

November 2024

Articles - They’re burning the labs... Spotlight Features - Incubators, Freezers & Cooling Equipment - Pumps, Valves & Liquid Handling - Clinical, Medical & Diagnostic Products News...

View all digital editions

Events

MEDICA 2024

Nov 11 2024 Dusseldorf, Germany

FILTECH

Nov 12 2024 Cologne, Germany

Intech

Nov 12 2024 Tel Aviv, Israel

analytica China

Nov 18 2024 Shanghai, China

Pharma Asia

Nov 20 2024 Karachi, Pakistan

View all events